GNB1L
Basic information
Region (hg38): 22:19783223-19854939
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GNB1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 33 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 35 | 10 | 13 |
Variants in GNB1L
This is a list of pathogenic ClinVar variants found in the GNB1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-19783263-C-T | Benign (May 09, 2019) | |||
22-19788716-C-T | not specified | Uncertain significance (Nov 29, 2023) | ||
22-19788720-G-C | not specified | Uncertain significance (Sep 10, 2024) | ||
22-19788743-C-T | not specified | Uncertain significance (May 03, 2023) | ||
22-19788749-T-C | not specified | Uncertain significance (Dec 14, 2023) | ||
22-19788760-C-T | GNB1L-related disorder | Likely benign (Oct 11, 2023) | ||
22-19788763-G-A | GNB1L-related disorder | Likely benign (Oct 28, 2019) | ||
22-19788773-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
22-19788777-C-G | not specified | Uncertain significance (Dec 26, 2023) | ||
22-19788781-G-A | GNB1L-related disorder | Likely benign (Jul 10, 2019) | ||
22-19788825-C-A | not specified | Uncertain significance (Feb 17, 2023) | ||
22-19788842-G-A | GNB1L-related disorder | Benign (Oct 28, 2019) | ||
22-19788857-A-G | not specified | Conflicting classifications of pathogenicity (Mar 20, 2024) | ||
22-19788858-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
22-19788859-G-A | GNB1L-related disorder | Benign (Dec 31, 2019) | ||
22-19788867-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
22-19788882-C-T | not specified | Uncertain significance (Nov 10, 2024) | ||
22-19788883-G-A | GNB1L-related disorder | Benign (Dec 31, 2019) | ||
22-19788899-C-T | not specified | Uncertain significance (May 26, 2023) | ||
22-19788914-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
22-19788925-G-A | Likely benign (Jul 18, 2018) | |||
22-19788930-C-T | Uncertain significance (May 25, 2017) | |||
22-19788956-C-T | not specified | Uncertain significance (May 23, 2024) | ||
22-19802005-A-T | not specified | Uncertain significance (Oct 08, 2024) | ||
22-19802018-A-C | GNB1L-related disorder | Benign (Oct 21, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GNB1L | protein_coding | protein_coding | ENST00000329517 | 6 | 71716 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000474 | 0.874 | 125619 | 0 | 105 | 125724 | 0.000418 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0200 | 235 | 236 | 0.996 | 0.0000172 | 2089 |
Missense in Polyphen | 49 | 55.345 | 0.88535 | 562 | ||
Synonymous | -0.251 | 112 | 109 | 1.03 | 0.00000848 | 703 |
Loss of Function | 1.43 | 9 | 15.0 | 0.601 | 7.30e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000555 | 0.000555 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.00241 | 0.00241 |
European (Non-Finnish) | 0.000241 | 0.000237 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.0000982 | 0.0000980 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Pathway
- Beta-agonist/Beta-blocker Pathway, Pharmacodynamics
(Consensus)
Intolerance Scores
- loftool
- 0.704
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.18
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- N
- hipred_score
- 0.167
- ghis
- 0.445
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gnb1l
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;social behavior;intracellular signal transduction
- Cellular component
- cytoplasm;cytoplasmic side of plasma membrane
- Molecular function
- molecular_function